1984
DOI: 10.1172/jci111509
|View full text |Cite
|
Sign up to set email alerts
|

Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels.

Abstract: Aatract. Prostaglandin I2 (PGI2), a potent vasodilator and inhibitor of platelet aggregation, is a major product of arachidonic acid metabolism in endothelial cells that are derived from large blood vessels (e.g., umbilical veins). We have examined whether PGI2 is also a major product of arachidonic acid metabolism in cultured endothelial cells that are derived from dermal microvessels in human newborn foreskin. Supernatants from confluent monolayers of endothelial cells that had been incubated for 20 min with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
34
1

Year Published

1987
1987
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 138 publications
(39 citation statements)
references
References 20 publications
4
34
1
Order By: Relevance
“…We also demonstrated that bradykinin-stimulated 13,14-dihydro-15-oxo-PGF2,, exhibits a similar time course of inhibition and recovery following aspirin to that of bradykinin-stimulated 6-oxo-PGF1*. It is likely that this metabolite reflects PGE2 production by microvascular endothelium (Charo et al, 1984;Barrow etal., 1987;Ritter et al, 1987a), suggesting that endothelial cyclo-oxygenase turns over rapidly in man. In contrast to our findings, Hamberg (1972) found that sodium salicylate, 750 mg four times daily for 3 days, substantially inhibited excretion of a urinary metabolite of E-series prostaglandins under basal conditions.…”
Section: Discussionsupporting
confidence: 53%
“…We also demonstrated that bradykinin-stimulated 13,14-dihydro-15-oxo-PGF2,, exhibits a similar time course of inhibition and recovery following aspirin to that of bradykinin-stimulated 6-oxo-PGF1*. It is likely that this metabolite reflects PGE2 production by microvascular endothelium (Charo et al, 1984;Barrow etal., 1987;Ritter et al, 1987a), suggesting that endothelial cyclo-oxygenase turns over rapidly in man. In contrast to our findings, Hamberg (1972) found that sodium salicylate, 750 mg four times daily for 3 days, substantially inhibited excretion of a urinary metabolite of E-series prostaglandins under basal conditions.…”
Section: Discussionsupporting
confidence: 53%
“…The heterogeneity of microvascular endothelial cells (MECs) derived from different organs [1][2][3][4][5][6] indicates strongly that these cells have specialised functions at different anatomical sites. Thus by studying the features of tissue-derived endothelium, we might gain considerable insight into the physiological and pathological processes taking place within a specific organ.…”
Section: Introductionmentioning
confidence: 99%
“…A deeper knowledge of tissue-derived endothelium might help us understand its physiological properties and the pathological processes occurring within a specific organ. It is, in fact, widely accepted that phenotype and function of microvascular endothelial cells (MECs) derived from different vascular beds are heterogeneous [3][4][5][6][7][8], supporting the proposal that tissue-specific vascular beds have specialised functions.…”
Section: Introductionmentioning
confidence: 99%
“…Most of our knowledge on the active participation of endothelial cells in physiopathological processes derives from studies on endothelial cells derived from umbilical vein, which are easily isolated and cultured [26]. However, it is conceivable that these large-vessel endothelial cells do not exhibit the phenotypic and functional characteristics of the relevant microvasculature [3][4][5][6][7][8]27]. Studies on the biology of microvascular endothelial cells are hampered by difficulties in isolating and culturing large numbers of pure cells from any organ, and by their limited life span.…”
Section: Introductionmentioning
confidence: 99%